S&P 500   3,975.33 (+1.90%)
DOW   31,910.97 (+2.08%)
QQQ   292.50 (+1.32%)
AAPL   142.49 (+3.56%)
MSFT   259.84 (+2.88%)
FB   194.54 (+0.52%)
GOOGL   2,223.47 (+2.08%)
AMZN   2,120.10 (-1.47%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.48 (-0.36%)
NIO   15.73 (-4.32%)
AMD   94.38 (+0.94%)
CGC   5.14 (-6.88%)
MU   69.44 (+0.78%)
T   20.89 (+2.40%)
GE   75.97 (+0.96%)
F   12.84 (+2.72%)
DIS   104.99 (+2.51%)
AMC   11.61 (-3.49%)
PFE   53.06 (+1.12%)
PYPL   81.00 (+0.57%)
NFLX   184.89 (-0.78%)
S&P 500   3,975.33 (+1.90%)
DOW   31,910.97 (+2.08%)
QQQ   292.50 (+1.32%)
AAPL   142.49 (+3.56%)
MSFT   259.84 (+2.88%)
FB   194.54 (+0.52%)
GOOGL   2,223.47 (+2.08%)
AMZN   2,120.10 (-1.47%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.48 (-0.36%)
NIO   15.73 (-4.32%)
AMD   94.38 (+0.94%)
CGC   5.14 (-6.88%)
MU   69.44 (+0.78%)
T   20.89 (+2.40%)
GE   75.97 (+0.96%)
F   12.84 (+2.72%)
DIS   104.99 (+2.51%)
AMC   11.61 (-3.49%)
PFE   53.06 (+1.12%)
PYPL   81.00 (+0.57%)
NFLX   184.89 (-0.78%)
S&P 500   3,975.33 (+1.90%)
DOW   31,910.97 (+2.08%)
QQQ   292.50 (+1.32%)
AAPL   142.49 (+3.56%)
MSFT   259.84 (+2.88%)
FB   194.54 (+0.52%)
GOOGL   2,223.47 (+2.08%)
AMZN   2,120.10 (-1.47%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.48 (-0.36%)
NIO   15.73 (-4.32%)
AMD   94.38 (+0.94%)
CGC   5.14 (-6.88%)
MU   69.44 (+0.78%)
T   20.89 (+2.40%)
GE   75.97 (+0.96%)
F   12.84 (+2.72%)
DIS   104.99 (+2.51%)
AMC   11.61 (-3.49%)
PFE   53.06 (+1.12%)
PYPL   81.00 (+0.57%)
NFLX   184.89 (-0.78%)
S&P 500   3,975.33 (+1.90%)
DOW   31,910.97 (+2.08%)
QQQ   292.50 (+1.32%)
AAPL   142.49 (+3.56%)
MSFT   259.84 (+2.88%)
FB   194.54 (+0.52%)
GOOGL   2,223.47 (+2.08%)
AMZN   2,120.10 (-1.47%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.48 (-0.36%)
NIO   15.73 (-4.32%)
AMD   94.38 (+0.94%)
CGC   5.14 (-6.88%)
MU   69.44 (+0.78%)
T   20.89 (+2.40%)
GE   75.97 (+0.96%)
F   12.84 (+2.72%)
DIS   104.99 (+2.51%)
AMC   11.61 (-3.49%)
PFE   53.06 (+1.12%)
PYPL   81.00 (+0.57%)
NFLX   184.89 (-0.78%)
OTCMKTS:POLXF

Polydex Pharmaceuticals Stock Competitors

$0.80
0.00 (0.00%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.80
$0.80
50-Day Range
$0.77
$1.07
52-Week Range
$0.77
$1.15
Volume
2 shs
Average Volume
4,663 shs
Market Capitalization
$2.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.44

Polydex Pharmaceuticals (OTCMKTS:POLXF) Vs. LIN, APD, JSCPY, TROX, MTX, KRO, LXU, VHI, LXFR, and NL

Should you be buying Polydex Pharmaceuticals stock or one of its competitors? The main competitors of Polydex Pharmaceuticals include Linde (LIN), Air Products and Chemicals (APD), JSR (JSCPY), Tronox (TROX), Minerals Technologies (MTX), Kronos Worldwide (KRO), LSB Industries (LXU), Valhi (VHI), Luxfer (LXFR), and NL Industries (NL). These companies are all part of the "industrial inorganic chemicals" industry.These companies are all part of the "industrial inorganic chemicals" industry.

Polydex Pharmaceuticals vs.

Linde (NYSE:LIN) and Polydex Pharmaceuticals (OTCMKTS:POLXF) are both oils/energy companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends.

Linde has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Polydex Pharmaceuticals has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500.

Linde currently has a consensus price target of $370.67, suggesting a potential upside of 15.79%. Given Linde's higher probable upside, equities research analysts plainly believe Linde is more favorable than Polydex Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Linde
1 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.67
Polydex Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Linde has higher revenue and earnings than Polydex Pharmaceuticals. Polydex Pharmaceuticals is trading at a lower price-to-earnings ratio than Linde, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Linde$30.79 billion5.22$3.83 billion$7.7641.23
Polydex Pharmaceuticals$4.86 million0.56$210 thousand-$0.07-11.43

Linde received 242 more outperform votes than Polydex Pharmaceuticals when rated by MarketBeat users. However, 69.11% of users gave Polydex Pharmaceuticals an outperform vote while only 68.70% of users gave Linde an outperform vote.

CompanyUnderperformOutperform
LindeOutperform Votes
327
68.70%
Underperform Votes
149
31.30%
Polydex PharmaceuticalsOutperform Votes
85
69.11%
Underperform Votes
38
30.89%

Linde has a net margin of 12.66% compared to Polydex Pharmaceuticals' net margin of -4.99%. Linde's return on equity of 12.62% beat Polydex Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Linde 12.66% 12.62% 6.93%
Polydex Pharmaceuticals -4.99% -3.63% -3.08%

73.0% of Linde shares are held by institutional investors. 0.7% of Linde shares are held by insiders. Comparatively, 12.9% of Polydex Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Linde had 6 more articles in the media than Polydex Pharmaceuticals. MarketBeat recorded 6 mentions for Linde and 0 mentions for Polydex Pharmaceuticals. Linde's average media sentiment score of 0.10 beat Polydex Pharmaceuticals' score of 0.00 indicating that Linde is being referred to more favorably in the media.

Company Overall Sentiment
Linde Neutral
Polydex Pharmaceuticals Neutral

Summary

Linde beats Polydex Pharmaceuticals on 15 of the 17 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POLXF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

Polydex Pharmaceuticals (OTCMKTS:POLXF) vs. Its Competitors

MetricPolydex PharmaceuticalsIndustrial inorganic chemicals IndustryMedical SectorOTCMKTS Exchange
Market Cap$2.75M$16.50B$4.29B$6.01B
Dividend YieldN/A2.31%2.11%36.15%
P/E Ratio-11.4310.3912.191.62
Price / Sales0.563.902,274.49264.78
Price / Cash5.47174.9522.5725.85
Price / Book0.435.614.174.57
Net Income$210K$499.24M$163.54M$699.67M
7 Day Performance3.90%4.30%2.01%14.34%
1 Month PerformanceN/A2.01%-11.78%9.49%
1 Year Performance-29.82%15.16%-30.08%51.04%

Polydex Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIN
Linde
2.9564 of 5 stars
$319.94
+1.5%
$370.67
+15.9%
+5.6%$160.84B$30.79B41.2372,327
APD
Air Products and Chemicals
2.9874 of 5 stars
$236.39
-0.5%
$303.87
+28.5%
-20.3%$52.42B$10.32B23.5420,875Dividend Announcement
Analyst Report
JSCPY
JSR
0.9665 of 5 stars
$28.55
+1.6%
N/A-3.0%$6.45B$3.04B-13.409,278
TROX
Tronox
3.2715 of 5 stars
$17.76
+0.5%
$26.80
+50.9%
-24.0%$2.77B$3.57B9.986,588Ex-Dividend
MTX
Minerals Technologies
2.3365 of 5 stars
$64.35
+0.1%
$81.00
+25.9%
-23.5%$2.12B$1.86B12.843,961Dividend Announcement
KRO
Kronos Worldwide
2.0915 of 5 stars
$17.92
+2.4%
$20.00
+11.6%
+4.1%$2.07B$1.94B13.682,248Dividend Announcement
Gap Up
LXU
LSB Industries
1.1598 of 5 stars
$19.76
+3.9%
N/A+292.5%$1.77B$556.24M-3.99545
VHI
Valhi
1.2431 of 5 stars
$46.19
+6.3%
N/A+68.5%$1.31B$2.30B8.352,248Gap Up
LXFR
Luxfer
3.3981 of 5 stars
$15.99
+1.3%
$27.00
+68.9%
-29.6%$451.53M$374.10M19.271,300News Coverage
Positive News
NL
NL Industries
1.7481 of 5 stars
$8.21
+6.3%
$7.00
-14.7%
+4.3%$400.67M$140.80M7.082,818Dividend Announcement
VNTR
Venator Materials
2.2531 of 5 stars
$1.84
+1.7%
$5.13
+178.8%
-61.1%$196.07M$2.21B-3.353,522
LBTI
Lithium & Boron Technology
0 of 5 stars
$1.01
+8.6%
N/A-36.1%$187.85M$6.17M0.0047Gap Down
TORM
TOR Minerals International
1.2664 of 5 stars
$3.00
flat
N/A+26.1%$10.62M$35.27M0.00125
BRCOQ
Beard
0.3333 of 5 stars
$0.00
-50.0%
N/AN/A$0.00N/A0.0015
CSGH
China Sun Group High-Tech
0 of 5 stars
$0.00
flat
N/AN/A$0.00N/A0.00264High Trading Volume
GNMP
The General Chemical Group
0.3333 of 5 stars
$0.01
flat
N/AN/A$0.00N/A0.00735
This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.